Anteris Technologies Receives FDA Clearance to Initiate Early Feasibility Study for its Novel TAVR…
Anteris Technologies Ltd, a structural heart company developing DurAVR, the world’s only balloon-expandable, 3D single-piece aortic valve shaped to…